SCHEDULE: Brown Capital Management Reduces OrthoPediatrics Stake Below 5%

Brown Capital Management, LLC reported a beneficial ownership of 4.31% in OrthoPediatrics Corp.'s Class A common stock as of September 30, 2025.

Summary

• Brown Capital Management, LLC filed an Amendment No. 10 to Schedule 13G regarding its beneficial ownership in OrthoPediatrics Corp.
• As of September 30, 2025, Brown Capital Management beneficially owned 1,081,220 shares of OrthoPediatrics Corp. Class A common stock.
• This ownership represents 4.31% of the Class A common stock outstanding.
• The firm holds sole voting power over 692,005 shares and sole dispositive power over 1,081,220 shares.
• Brown Capital Management, LLC is an investment adviser and holds these shares for various investment advisory clients.
• The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 5

Explanation: The filing is a routine disclosure of beneficial ownership by an investment adviser. It indicates a continued investment in OrthoPediatrics Corp. but a reduction below the 5% threshold, which is a neutral event in itself, primarily for transparency.

Future Outlook

This filing does not provide forward-looking statements or guidance from the issuer or the reporting person regarding the issuer's future performance.

Management Comments

• "The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities."
• "All of the shares set forth in Item 4 are owned by various investment advisory clients of Brown Capital Management, LLC, which is deemed to be a beneficial owner of those shares pursuant to Rule 13d-3 under the Securities Exchange Act of 1934, due to its discretionary power to make investment decisions over such shares and/or its ability to vote such shares."

Industry Context

This filing is a routine disclosure of an investment adviser's stake in a publicly traded company and does not provide broader industry context.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional investor's reduced stake, confirming their continued but smaller position.
• Company Management: Awareness of a major institutional investor's position and its change.

Key Dates

Keywords

OrthoPediatrics Corp, Brown Capital Management, Schedule 13G, beneficial ownership, Class A common stock, investment adviser, equity stake, SEC filing